EpiCept Announces Receipt of Nasdaq Notice
EpiCept Corporation:Robert W. Cook, 914-606-3500rcook@epicept.comorMedia:Feinstein Kean HealthcareGreg Kelley, 617-577-8110gregory.kelley@fkhealth.coorInvestors:Lippert/Heilshorn & AssociatesKim Sutton Golodetz, 212-838-3777kgolodetz@lhai.comorBruce Voss, 310-691-7100bvoss@lhai.com